Journal SAM (June 2012): Oncologic PET/MRI Part I: Tumors of the Brain, Head and Neck, Chest, and Abdomen and Pelvis

MOC Part II SAM Modules

Journal SAM:  Oncologic PET/MRI Part I: Tumors of the Brain, Head and Neck, Chest, and Abdomen and Pelvis

Member Fee:  Free
Non-Member Fee:  $90.00

Release Date: 6/1/2012
Expiration Date: 6/30/2015

Continuing Education Credit Information

The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment.  2.0 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. 

Upon successful completion of this activity, participants should be able to describe:

The advantages and disadvantages of PET/MRI in oncologic applications in comparison to conventional imaging methods and PET/CT. 
2. The limitations of PET/MRI compared with invasive staging procedures (biopsy)
3. The metabolic/anatomic imaging procedure of choice (PET/MRI vs. PET/CT) based on tumor entity and location.

Target Audience

Journal SAMs are designed for all nuclear medicine specialists and other physicians, pharmacists and technologists who practice diagnostic and/or therapeutic nuclear medicine.

Faculty Disclosure(s)

Christian Buchbender, Till A. Heusner, Thomas C. Lauenstein, Andreas Bockisch, and Gerald Antoch.

The authors of this article have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest.